Skip to main content
. 2022 Aug 1;61(3):112. doi: 10.3892/ijo.2022.5402

Figure 4.

Figure 4

HHLA2 knockdown inhibits the EMT process in GBC cells in vitro. (A) HHLA2 expression was significantly decreased after transfection with the HHLA2 shRNA (n=3), (B) according to the quantification. (C) Expression of EMT markers Col-I, N-cadherin, α-SMA and vimentin were decreased whilst that of E-cadherin was increased in GBC cells transfected with the HHLA2 shRNA, (D) according to subsequent quantification. (E) Immunofluorescence staining revealed similar results to western blotting. Scale bars, 100 µm. Green, target protein; Blue, DAPI.**P<0.01 and ***P<0.001 (shHHLA2 group vs. sh-NC group). HHLA2, human endogenous retrovirus-H long terminal repeat-associating protein 2; EMT, epithelial-mesenchymal transition; Col-I, collagen I; α-SMA, α-smooth muscle actin; shRNA or sh, short hairpin RNA; GBC, gall bladder cancer; NC, negative control.